Progressive cerebral and coronary aneurysms in the original two patients with Kosaki overgrowth syndrome
Progressive cerebral and coronary aneurysms in the original two patients with Kosaki overgrowth syndrome
复制标题
最初两名小崎过度生长综合征患者的进行性脑动脉瘤和冠状动脉瘤
DOI:
10.1002/ajmg.a.62027
复制
发表时间:
2020
影响因子:
2
通讯作者:
Kosaki Kenjiro
中科院分区:
文献类型:
--
作者:
Takenouchi Toshiki;Kodo Kazuki;Yamazaki Fumito;Nakatomi Hirofumi;Kosaki Kenjiro
Skeletal overgrowth accompanied by de novo heterozygous activating mutations inPDGFRB(platelet‐derived growth factor receptor beta), that is,p.Pro584Arg and p.Trp566Arg, defines Kosaki overgrowth syndrome (OMIM #616592). Emerging evidence suggests a role of PDGFRB in the genesis of cerebral aneurysms. The delineation of the range and progression of the vascular phenotype of Kosaki overgrowth syndrome is urgently needed. Herein, we conducted subsequent analyses of serial neurovascular imaging studies of two original patients with a de novo heterozygous mutation inPDGFRB, that is, p.Pro584Arg. The analysis showed the progressive dilation of basilar and vertebral arteries and coronary arteries commencing during the teenage years and early 20s. The radiographic appearance of the basilar vertebral aneurysms showed signs of arterial wall dilation, compatible with the known vascular pathology of vascular‐type Ehlers‐Danlos syndrome and Loeys‐Dietz syndrome. The dolichoectasia in cerebrovascular arteries can lead to fatal complications, even with neurosurgical interventions. To prevent the progression of artery dilation, preventative and therapeutic medical measures using tyrosine kinase inhibitors may be necessary in addition to optimal control of the systemic blood pressure. Kosaki overgrowth syndrome is a clinically recognizable syndrome that can exhibit progressive dilatory and tortuous vascular changes in basilar/vertebral and coronary arteries as early as in the teenage years. We recommend careful counseling regarding the risk of future vascular complications, optimal blood pressure control, and regular systemic vascular screening during follow‐up examinations.
登录
查看更多内容
影响因子:
11.8
作者:
Olson, Lorin E.;Soriano, Philippe
通讯作者:
Soriano, Philippe
DOI:
10.1016/j.jvs.2006.10.011
发表时间:
2006-12
期刊:
The New England journal of medicine
影响因子:
--
作者:
B. Loeys;U. Schwarze;Tammy M. Holm;B. Callewaert;G. Thomas;H. Pannu;J. De Backer;Gretchen L. Oswald;S. Symoens;S. Manouvrier;A. Roberts;F. Faravelli;M. Greco;R. Pyeritz;D. Milewicz;P. Coucke;D. Cameron;A. Braverman;P. Byers;A. De Paepe;H. Dietz
通讯作者:
B. Loeys;U. Schwarze;Tammy M. Holm;B. Callewaert;G. Thomas;H. Pannu;J. De Backer;Gretchen L. Oswald;S. Symoens;S. Manouvrier;A. Roberts;F. Faravelli;M. Greco;R. Pyeritz;D. Milewicz;P. Coucke;D. Cameron;A. Braverman;P. Byers;A. De Paepe;H. Dietz
影响因子:
8.3
作者:
HirofumiNakatomi;HiromuSegawa;AtsushiKurata;YoshiakiShiokawa;KazuyaNagata;HiroyasuKamiyama;KeisukeUeki;TakaakiKirino
通讯作者:
TakaakiKirino
影响因子:
2
作者:
Flore Zufferey;S. Hadj;Annachiara De Sandre;J. Dufier;B. Leheup;Cyril Schweitze;C. Bodemer;V. Cormier;M. le Merrer
通讯作者:
M. le Merrer
影响因子:
3.6
作者:
Zhiyong Zhang;Shuguang Zheng;Song Zheng;Yanyan Wang;Xue;Xing;Hong
通讯作者:
Hong